Sale by Krishnaswamy Yeleswaram (Chief Development Officer)
20,225 shares · @ $39.99 · $808,844
Rapport Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $37.11
-9.7% in 3d after detection
Post-detection moves
1h
—
1d
-3.2%
3d
-9.7%
7d
-2.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS